Anavex Life Sciences Corp.AVXLNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-34.08M
↓ 38% vs avg
Percentile
P7
Near historical low
Streak
1 yr
Consecutive growthContracting
Average
$-24.78M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-34.08M | +12.7% |
| 2025 | $-39.04M | -26.7% |
| 2024 | $-30.81M | -10.9% |
| 2023 | $-27.79M | -14.6% |
| 2022 | $-24.24M | +20.2% |
| 2021 | $-30.38M | -42.7% |
| 2020 | $-21.29M | -14.9% |
| 2019 | $-18.53M | -47.2% |
| 2018 | $-12.58M | -39.5% |
| 2017 | $-9.02M | - |